CompletedPhase 1/2

The Herbal Acupoint Patch for Dialysis Patient With Fistula-related Pain

Taiwan21 participantsStarted 2024-02-15

Plain-language summary

To evaluate the effect of a traditional Chinese medicine (TCM) intervention on pain relief, mood and quality of life (QOL) in hemodialytic patients at a dialysis center in Southern Taiwan.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * maintenance HD \> 6 months , * reporting fistula pain during HD sessions that was associated with a hypersensitive palpable nodule in a taut band, at least 6 times in the past month, * a NRS pain score \>4, * no changes in pain relievers such as NSAIDs, opioids, topical ointments, or muscle relaxants over the past week, * voluntarily agreed to participate in the trial and presented written informed consent. Exclusion Criteria: * severe comorbid organ dysfunction, * existence of cervical radiculopathy or thoracic outlet syndrome * inflammation of the skin or soft tissue at the fistula site, * dementia, * psychiatric diseases, * allergy to herbal patch * currently participating in other clinical studies

What they're measuring

Brief Pain Inventory (BPI)

Timeframe: Weeks 0 (baseline), 2, 4, and 6 (2 weeks of follow-up)

Trial details

NCT IDNCT07380581

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More End Stage Chronic Renal Failure trials